New virus is capable of attacking 99% of HIV strains
According to the International Aids Society this is an exciting breakthrough. Human trials will begin in 2018 to see if it is possible to prevent or treat infections. According to Linda-Gail Bekker, the group's president, these antibodies seem to go beyond the natural and may have applications than anticipated.
How the antibody works
Researchers explain that in our body we have antibodies that fight to combat HIV. Unfortunately, this virus has a great ability to modify itself, making it difficult for the immune system to function.
However, some patients are able to develop broad, attacking neutralizing antibodies capable of killing extensions of HIV strains. The scientists' creation combines three broadly neutralizing types of antibodies as a way to treat HIV, or prevent infection. They are more powerful and more efficient than the ones we have in our body.
So far, the experiment was done with 24 monkeys and experts realized that they had an impressive degree of protection.
The most common side effects are numbness, tingling and a small pain at the injection site. These effects are usually not severe and most often subside within a few hours of the injection. In some cases, other more serious side effects may occur, such as difficulty breathing, swelling, itching, or throat closure.
Pain or discomfort in the chest region is one of the major signs of a heart attack, but a study conducted in the United States suggests that women are not as likely to have this symptom as men. The research also states that the risk of death from the attack is greater among the female audience. Published in the Journal of the American Medical Association (JAMA), the finding was made from data analysis of the National Registry of Myocardial Infarction between 1994 and 2006.